Literature DB >> 23102816

Pre-incision antibiotic prophylaxis reduces the incidence of post-caesarean surgical site infection.

J Brown1, M Thompson, S Sinnya, A Jeffery, C de Costa, C Woods, P Howat, A Raulli.   

Abstract

A two-part prospective study was conducted to assess rates of surgical site infection (SSI) following caesarean section in a large Australian regional hospital before and after a change of timing of antibiotic prophylaxis from after cord clamping to pre-incision. SSI rates dropped from 10.8% in 2010 to 2.8% in 2011 with no adverse neonatal consequences, providing further evidence that antibiotic prophylaxis should be given pre-incision for caesarean section in hospitals in Australia and New Zealand, as is now accepted practice elsewhere.
Copyright © 2012 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Mesh:

Year:  2012        PMID: 23102816     DOI: 10.1016/j.jhin.2012.08.014

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  3 in total

Review 1.  The Use of Copper as an Antimicrobial Agent in Health Care, Including Obstetrics and Gynecology.

Authors:  Linda P Arendsen; Ranee Thakar; Abdul H Sultan
Journal:  Clin Microbiol Rev       Date:  2019-08-14       Impact factor: 26.132

2.  Reliability and validity of using telephone calls for post-discharge surveillance of surgical site infection following caesarean section at a tertiary hospital in Tanzania.

Authors:  Boniface Nguhuni; Pasquale De Nardo; Elisa Gentilotti; Zainab Chaula; Caroline Damian; Paola Mencarini; Emanuele Nicastri; Arnold Fulment; Alessandro Piscini; Francesco Vairo; Alexander M Aiken; Giuseppe Ippolito
Journal:  Antimicrob Resist Infect Control       Date:  2017-05-08       Impact factor: 4.887

3.  Surgical site infections following caesarean sections at Emirati teaching hospital: Incidence and implicated factors.

Authors:  Munther S Alnajjar; Dalia A Alashker
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.